SLC6A14 and cancer: Based on the role of SLC6A14 in cancer cell metabolism and growth, and the finding that Panc-1 is more malignant than AsPC-1 [48,49], the data suggest that alloferon could be used as a chemo-adjuvant drug to regulate metastasis and the proliferation of more aggressive cancers.